Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Metformin Testing Prompts New Finding Of NDMA And Cancer Risk
FDA Asks Several Manufacturers To Recall Products In US
Jun 02 2020
•
By
Joanne S. Eglovitch
FDA issues new findings about NDMA in metformin • Source: Shutterstock
More from Manufacturing
More from Business